Search by Drug Name or NDC
NDC 00310-4700-01 LUMOXITI 1 mg/mL Details
LUMOXITI 1 mg/mL
LUMOXITI is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AstraZeneca Pharmaceuticals LP. The primary component is MOXETUMOMAB PASUDOTOX.
MedlinePlus Drug Summary
Moxetumomab pasudotox-tdfk injection is used to treat hairy cell leukemia (cancer of a certain type of white blood cell) that has returned or has not responded after at least two other cancer treatments. Moxetumomab pasudotox-tdfk injection is in a class of medications called monoclonal antibodies. It works by helping your immune system to slow or stop the growth of cancer cells.
Related Packages: 00310-4700-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Moxetumomab Pasudotox-tdfk Injection
Product Information
| NDC | 00310-4700 |
|---|---|
| Product ID | 0310-4700_bd80307f-5490-4eda-a787-423a7ca788cc |
| Associated GPIs | 21352236502120 |
| GCN Sequence Number | 079139 |
| GCN Sequence Number Description | moxetumomab pasudotox-tdfk VIAL 1 MG INTRAVEN |
| HIC3 | V38 |
| HIC3 Description | ANTINEOPLASTIC-CD22 DIRECT ANTIBODY/CYTOTOXIN CONJ |
| GCN | 45585 |
| HICL Sequence Number | 045363 |
| HICL Sequence Number Description | MOXETUMOMAB PASUDOTOX-TDFK |
| Brand/Generic | Brand |
| Proprietary Name | LUMOXITI |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | moxetumomab pasudotox |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 1 |
| Active Ingredient Units | mg/mL |
| Substance Name | MOXETUMOMAB PASUDOTOX |
| Labeler Name | AstraZeneca Pharmaceuticals LP |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA761104 |
| Listing Certified Through | n/a |
Package
NDC 00310-4700-01 (00310470001)
| NDC Package Code | 0310-4700-01 |
|---|---|
| Billing NDC | 00310470001 |
| Package | 1 VIAL in 1 CARTON (0310-4700-01) / 1 mL in 1 VIAL |
| Marketing Start Date | 2018-10-24 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |